On 16 August, Ashish Adukia was appointed as the global Chief Financial Officer (CFO), and key managerial personnel of Cipla Ltd approval was given by the board of directors (BOD). Dinesh Jain, the new appointment, will relieve the additional responsibility of the interim CFO. He will continue with the company as senior vice president and head of corporate finance. Ashish Adukia is a Chartered Accountant (CA) and MMS (Finance) from JBIMS. In 2017, he featured in Fortune India’s 40 under 40 lists.

• Coal India, AMNS Sign MoU on Syn-Gas at Paradip Plant
• HAL Hits 52-Week High of Rs 5,055 on Strong Q1 Results
• MP Approves Rs 1,757 Crore Bhopal-Vidisha Road Project
• Nvidia Reportedly Developing 1 Trillion-Parameter AI Model
• West Coast Paper Hits 52-Week High on Strong Q1 Profit

Cipla is a global pharmaceutical company focused on agile and sustainable growth, complex generics, and deepening portfolio in our home markets of India, South Africa, North America, and key regulated and emerging markets.

The consolidated net profit of Cipla Ltd has slipped 4 per cent to Rs 686.40 crore on a 2.3 per cent decline in total revenue from operations to Rs 5,375.19 crore in Apr-Jun quarter of FY23 over the same period of last year. Also, the stock of Cipla Ltd went down by 0.18 per cent to Rs 1,032 on the Bombay Stock Exchange (BSE).